Auro Laboratories Ltd.

192.00 ▼0%

12 April 2024, 04:01:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aurolabs.com
Market Cap 116.98 Cr.
Enterprise Value(EV) 125.35 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 11.54 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 16.26 Trailing Twelve Months Ending 2023-12
Industry PE 41.38 Trailing Twelve Months Ending 2023-12
Book Value / Share 63.77 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.94 Calculated using Price: 187.70
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.62 Cr. 6,232,500 Shares
FaceValue 10
About Auro Laboratories Ltd.
Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations. The company is promoted by Shri Sharat Deorah and Shri Satish Deorah.

Auro Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Auro Laboratories Ltd. Performance

1 Day
1 Week
+4.77%
1 Month
+26.57%
3 Month
+50.71%
6 Month
+62.64%
1 Year
+178.26%
2 Year
+76.63%
5 Year
+170.80%
10 Year
+3068.32%

Auro Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 11.01 10.83 9.06 31.53 28.95 20.84 28.67 9.47 7.43
Return on Capital Employed (%) 10.76 11.21 20.24 28.65 29.12 24.8 38.88 12.2 9.92
Return on Assets (%) 2.89 3.24 3.11 12.34 13.78 12.32 19.34 5.87 4.4

Auro Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 8 9 9 13 17 22 29 32 34 37
Non Curr. Liab. 8 7 11 8 6 5 4 3 4 11
Curr. Liab. 14 10 6 10 10 6 9 20 18 14
Minority Int.
Equity & Liab. 29 26 27 30 33 32 42 55 56 62
Non Curr. Assets 11 13 13 15 15 14 14 18 21 26
Curr. Assets 18 12 14 16 19 18 28 37 35 36
Misc. Exp. not W/O
Total Assets 29 26 27 30 33 32 42 55 56 62

Auro Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 33 28 35 41 47 44 54 51 53 55
Other Income 0 0 1 1 1 1 1 1 1 2
Total Income 33 28 36 41 48 45 55 52 54 57
Total Expenditure -30 -25 -31 -34 -40 -38 -43 -46 -49 -44
PBIDT 3 3 5 7 8 7 12 6 5 12
Interest -2 -2 -1 -1 -1 -1 0 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -2 -1 -2 -2 -3 -1 -1 -3
Exceptional Items
PAT 1 1 1 4 4 4 7 3 2 7
Adjusted EPS 1 1 1 6 7 7 12 5 4 12

Auro Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 -1 8 6 5 7 9 13 -7 3
Cash Fr. Inv. -1 -1 -2 -2 -2 -3 -2 -4 -5 -5
Cash Fr. Finan. -3 1 -5 -4 -2 -2 -6 0 10 -8
Net Change 1 -1 0 0 1 2 2 9 -2 -10
Cash & Cash Eqvt 1 0 1 1 2 4 6 15 12 2

Auro Laboratories Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 51.99 52.09 52.09 52.09 52.09 52.09 52.09 52.09 52.15
Public 48.01 47.91 47.91 47.91 47.91 47.91 47.91 47.91 47.85
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Auro Laboratories Ltd. Announcements

Fri, 05 Apr 2024
Compliance Certificate Under Reg 7(3) Of SEBI LODR Regulations 2015 For The Year Ended March 31 2024
Attached Compliance certificate under reg 7(3) of SEBI LODR Regulations 2015 for year ended March 31 2024
Fri, 05 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation for the quarter ended March 31 2024.
Mon, 01 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for issue of duplicate share certificates under Regulation 39(3) of SEBI (Listing and Disclosure Obligations Requirements) Regulations 2015

Auro Laboratories Ltd. Technical Scans

Fri, 12 Apr 2024
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Auro Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,413.61 1,517.60 -1.4%
Cipla Ltd. 112,740.74 1,389.95 -0.5%
Dr. Reddy's Laboratories Ltd. 101,499.74 6,073.20 -0.2%
Divi's Laboratories Ltd. 100,325.89 3,770.00 -0.3%
Zydus Lifesciences Ltd. 96,734.30 950.00 -1.3%
Mankind Pharma Ltd. 92,896.46 2,256.00 -2.8%
Apollo Hospitals Enterprise Ltd. 92,081.85 6,325.10 -1.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.48 1,517.60 -1.4%
Cipla Ltd. Consolidated 2023-12 30.40 1,389.95 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.41 6,073.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 72.54 3,770.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.53 950.00 -1.3%
Mankind Pharma Ltd. Consolidated 2023-12 53.79 2,256.00 -2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 116.66 6,325.10 -1.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.92 1,517.60 -1.4%
Cipla Ltd. Consolidated 2023-12 4.35 1,389.95 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.78 6,073.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 7.70 3,770.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.13 950.00 -1.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.46 2,256.00 -2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.63 6,325.10 -1.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,517.60 -1.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,389.95 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,073.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,770.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 950.00 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,256.00 -2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,325.10 -1.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,517.60 -1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,389.95 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,073.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,770.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 950.00 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,256.00 -2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,325.10 -1.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,517.60 -1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,389.95 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,073.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,770.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 950.00 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,256.00 -2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,325.10 -1.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,517.60 -1.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,389.95 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,073.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,770.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 950.00 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,256.00 -2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,325.10 -1.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,517.60 -1.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,389.95 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,073.20 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,770.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 950.00 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,256.00 -2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,325.10 -1.3%

Auro Laboratories Ltd. FAQ's

What is Auro Laboratories share price?

Can I buy Auro Laboratories shares now?

What is the Market Cap of Auro Laboratories?

What are the key metrics to analyse Auro Laboratories?

What is the 52 Week High and Low of Auro Laboratories?